Ocean Biomedical, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Poseidon Bio, LLC | — | Other | 500,000 | — | — | 22,342,756 | Oct 2, 2023 |
| AJJARAPU SURENDRA K | — | Other | 1,050,000 | — | — | 315,000 | Mar 22, 2023 |
| AJJARAPU SURENDRA K | — | Other | 21,252 | — | — | 21,252 | Feb 28, 2023 |
| Aesther Healthcare Sponsor, LLC | — | Other | 2,625,000 | — | — | 1,365,000 | Feb 28, 2023 |
| PETERSON MICHAEL L | — | Other | 80,000 | — | — | 80,000 | Feb 28, 2023 |
| Poseidon Bio, LLC | — | Other | 22,842,756 | — | — | 22,842,756 | Feb 14, 2023 |
| Aesther Healthcare Sponsor, LLC | — | C | 2,625,000 | — | — | 3,990,000 | Feb 14, 2023 |